Axsome Therapeutics (AXSM) Offers Investors Hope - Mizuho Securities

August 23, 2021 9:43 AM

Mizuho Securities analyst Vamil Divan reiterated a Buy rating and $55.00 price target on Axsome Therapeutics (NASDAQ: AXSM) after the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found